Browsing by Author "Ascher-Svanum, Haya"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
Item Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence(DOVE MEDICAL PRESS LTD, PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND, 2010) Kelin, Katarina; Brnabic, Alan J.M.; Newton, Richard; Escamilla, Raúl I.; Chuo, Liang-Jen; Simu, Malina; Ye, Wenyu; Montgomery, William; Karagianis, Jamie; Ascher-Svanum, Haya; Eli Lilly Australia Pty Ltd, 112 Wharf Rd, W Ryde, NSW 2114, Australia; kelin_katarina@lilly.comItem Socio-demographic characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment non-adherence(ELSEVIER SCIENCE BV, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS, 2010) Kelin, Katarina; Newton, Richard; Simu, Malina I.; Chuo, Liang-Jen; Escamilla, Raúl I.; Granger, Renee E.; Ye, Wendy; Brnabic, Alan J.M.; Montgomery, William; Ascher-Svanum, Haya; Karagianis, Jamie; Eli Lilly Australia Pty Ltd, 112 Wharf Rd, W Ryde, NSW 2114, Australia; kelin_katarina@lilly.comItem Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence(2011) Kelin, Katarina; Lambert, Timothy J.R.; Brnabic, Alan J.M.; Newton, Richard; Ye, Wendy; Escamilla, Raúl I.; Chen, Kuang-Peng; Don, Liana; Montgomery, William; Karagianis, Jamie; Ascher-Svanum, Haya; Eli Lilly Australia Pty Ltd, West Ryde, NS W, Australia; kelin_katarina@lilly.com